Compare Moderna, Inc. (MRNA) vs Vanguard S&P 500 ETF (VOO) Price & Performance

Moderna, Inc.Trade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Vanguard S&P 500 ETF — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Vanguard S&P 500 ETF trades at $687.51. The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

	MRNA	VOO
Market Cap	$23.60B	—
Sector	Health	Broad Market / Factor
52-Week High	$81.80	$698.29
52-Week Low	$22.36	$571.45
Enterprise Value	$19.70B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 12 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

VOO

DIA ETF underperforms S&P 500 ETFs due to higher fees and price-weighted index design.24/7 Wall Street · 3 days agoBearish SPY ETF charges higher fees than its cheaper sibling SPYM with identical S&P 500 exposure.24/7 Wall Street · 4 days agoBearish S&P 500 falls 1.6% for the week, dipping below its 50-day moving average amid ongoing market volatility.ETF Trends · 4 days agoBearish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.